Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)- Related Outcomes in Korea: A Nationwide Population-based Cohort StudyArticle Published on 2020-10-152023-07-02 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, [키워드] ACEi/ARB Comorbidity COVID-19 renin-angiotensin system SARS-CoV-2 [DOI] 10.1093/cid/ciaa624 PMC 바로가기
Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: Systematic review and meta-analysisOriginal Paper Published on 2020-08-272022-10-29 Journal: IJC Heart & Vasculature [Category] COVID-19, [키워드] 95% confidence interval 95%CI ACEi/ARB acute lung injury acute respiratory distress syndrome all-cause mortality Analysis angiotensin-converting enzyme inhibitor Angiotensin-receptor blocker animal ARB association blocker Collection core coronavirus COVID-19 disease COVID-19 infection disease severity enzyme estimate evaluate Evidence facilitate GRADE framework higher risk hypertensive patient Infection inhibitor Meta-analysis moderate Mortality mortality risk objective Odds ratio patients with COVID-19 performed Positive test potential benefit PsycINFO Random-effects meta-analysis required Result risk risk of COVID-19 robust SARS-CoV-2 searched severe COVID-19 disease significant decrease Stage suggested the disease the SARS-CoV-2 Web of Science were expressed [DOI] 10.1016/j.ijcha.2020.100627 PMC 바로가기 [Article Type] Original Paper
Effect of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19: a Systematic Review and Meta-analysis of 28,872 PatientsEvidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor) Published on 2020-08-242022-10-31 Journal: Current Atherosclerosis Reports [Category] COVID-19, MERS, [키워드] 95% confidence interval ACEi/ARB angiotensin receptor blocker angiotensin-converting enzyme inhibitor ARB ARBs association Cohort Combination condition coronavirus COVID Covid patients COVID-19 case COVID-19 pandemic Critical database death Effect evaluated event Evidence finding hypertension hypertensive imperative inhibitor inhibitors lower risk mean difference Meta-analysis mortality data outcome Patient RAAS recent renin-angiotensin-aldosterone system review searched supplementary material System were used with COVID-19 [DOI] 10.1007/s11883-020-00880-6 PMC 바로가기 [Article Type] Evidence-Based Medicine, Clinical Trials and Their Interpretations (L. Roever, Section Editor)
Association of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with risk of COVID ‐19, inflammation level, severity, and death in patients with COVID ‐19: A rapid systematic review and meta‐analysisReview Published on 2020-08-052022-10-31 Journal: Clinical Cardiology [Category] COVID-19, [키워드] ACE ACEi/ARB ARBs association bioRxiv blocker CD3 CD8 Clinical outcome confounder confounders coronavirus disease COVID COVID‐19 COVID‐19 infection COVID‐19 death elevated enzyme Evidence General population hypertension Immune cell increased risk Infectious disease Inflammation Inflammatory inhibitor lower mortality lung medRxiv Mortality Odds ratio Patient patients Pneumonia receiving receptor reduced risk SARS‐CoV‐2 searched severity significant increase subgroup analysis systematic review therapy [DOI] 10.1002/clc.23421 PMC 바로가기 [Article Type] Review
Renin-Angiotensin-Aldosterone System Blockers Are Not Associated With Coronavirus Disease 2019 (COVID-19) Hospitalization: Study of 1,439 UK Biobank CasesCardiovascular Medicine Published on 2020-07-142022-10-31 Journal: Frontiers in Cardiovascular Medicine [Category] COVID-19, [키워드] ACEi/ARB adjusted adverse outcome age angiotensin Angiotensin converting enzyme inhibitors Angiotensin receptor blockers ARBs Asian association associations Bame black blocker BMI body mass index cardiometabolic cardiometabolic disease Cohort comparison coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 negative diabetes Enzyme inhibitor Ethnicity Factor greater hospital Hospitalization hypertension increased risk individual Male sex medications moderate morbidity Myocardial infarction obesity Other participant positive positive result Regression model severe symptom Sex smoking specificity System tested UK biobank were used with COVID-19 [DOI] 10.3389/fcvm.2020.00138 PMC 바로가기 [Article Type] Cardiovascular Medicine
COVID-19 with Different Severities: A Multicenter Study of Clinical FeaturesArticle Published on 2020-06-012023-07-01 Journal: American Journal of Respiratory and Critical Care [Category] SARS, [키워드] ACEi/ARB COVID-19 multiple lung lobe involvement pleural effusion severity [DOI] 10.1164/rccm.202002-0445OC PMC 바로가기
Coronavirus Disease 2019 (COVID-19) and Cardiovascular Disease: A Viewpoint on the Potential Influence of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers on Onset and Severity of Severe Acute Respiratory Syndrome Coronavirus 2 InfectionComment Published on 2020-04-072023-07-14 Journal: Journal of the American Heart Association [Category] SARS, [키워드] ACEi/ARB angiotensin‐converting enzyme 2 cardiovascular disease COVID‐19 SARS‐CoV‐2 [DOI] 10.1161/JAHA.120.016219 PMC 바로가기 [Article Type] Comment